Range
- - -
Vol / Avg.
2K/2M
Div / Yield
-
52 Wk
185.64 - 306.08
Mkt Cap
48.6B
Payout Ratio
-
Open
-
P/E
17.91
EPS
2.52
Shares
258.9M
Outstanding
258.9M
Total Float
258.7M
load more
Sector: Health Care.Industry: Biotechnology
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex's pipeline includes gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease as well as small-molecule medicines targeting diseases associated with alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease. Vertex also has an expanding research pipeline focused on inflammatory diseases, non-opioid treatments for pain, and genetic and cell therapies for type 1 diabetes and rare diseases.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-07-29
REV
Q1 2021Est.ActualSurprise
EPS2.6902.980 0.2900
REV1.660B1.724B64.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
VRTXVertex Pharmaceuticals0.61%48.6B

Vertex Pharmaceuticals Frequently Asked Questions

Q

How do I buy Vertex Pharmaceuticals (VRTX) stock?

A

You can purchase shares of Vertex Pharmaceuticals (NASDAQ: VRTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Vertex Pharmaceuticals's (VRTX) competitors?

Q

What is the target price for Vertex Pharmaceuticals (VRTX) stock?

A

The latest price target for Vertex Pharmaceuticals (NASDAQ: VRTX) was reported by Piper Sandler on June 14, 2021. The analyst firm set a price target for 261.00 expecting VRTX to rise to within 12 months (a possible 38.94% upside). 34 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Vertex Pharmaceuticals (VRTX)?

A

The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $187.85 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Vertex Pharmaceuticals (VRTX) pay a dividend?

A

There are no upcoming dividends for Vertex Pharmaceuticals.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A
Vertex Pharmaceuticals’s Q2 earnings are confirmed for after-market on July 29, 2021.
Q

Is Vertex Pharmaceuticals (VRTX) going to split?

A

There is no upcoming split for Vertex Pharmaceuticals.

Q

What sector and industry does Vertex Pharmaceuticals (VRTX) operate in?

A

Vertex Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.